Friday, March 8, 2019

Identification of a novel missense mutation in Friedreich's ataxia –FXNW168R

›
Clark, E. , Strawser, C. , Schadt, K. and Lynch, D. R. (2019), Ann Clin Transl Neurol. doi:10.1002/acn3.728 Friedreich's ataxia, chara...
Thursday, March 7, 2019

Structure of the human frataxin-bound iron-sulfur cluster assembly complex provides insight into its activation mechanism

›
Nicholas G Fox, Xiaodi Yu, Xidong Feng, Henry J Bailey, Alain Martelli, Joseph F. Nabhan, Claire Strain-Damerell, Christine Bulawa, Wyatt W....
Wednesday, March 6, 2019

Case 3: Gait Instability and Elevated Troponin Level in a 16-year-old Boy

›
Carrie Johnson, Shaun Mohan; Pediatrics in Review Feb 2019, 40 (2) 85-87; DOI: 10.1542/pir.2017-0095 Given the findings of hypertrophic ca...
Tuesday, March 5, 2019

In Vitro interaction between yeast frataxin and superoxide dismutases: Influence of mitochondrial metals

›
Thi Hong Lien Han, Jean-Michel Camadro, Florent Barbault, Renata Santos, Jean-Michel El Hage Chahine, Nguyet-Thanh Ha-Duong; Biochimica et B...
Monday, March 4, 2019

Randomized, double‐blind, placebo‐controlled study of interferon‐γ 1b in Friedreich Ataxia

›
Lynch, D. R., Hauser, L. , McCormick, A. , Wells, M. , Dong, Y. N., McCormack, S. , Schadt, K. , Perlman, S. , Subramony, S. H., Mathews, K....
Sunday, March 3, 2019

Structure of the human frataxin-bound iron-sulfur cluster assembly complex provides insight into its activation mechanism

›
Nicholas G Fox, Xiaodi Yu, Xidong Feng, Henry J Bailey, Alain Martelli, Joseph F. Nabhan, Claire Strain-Damerell, Christine Bulawa, Wyatt W....
Friday, March 1, 2019

Researchers from Lleida make advances to propose new therapies in the treatment of Friedreich's ataxia

›
Communication and Press IRBLleida, February 28, the World Day of Minority Diseases. The Oxidative Stress Biochemical Research Group, of th...

C-Path, FARA launch Friedreich's Ataxia Clinical Database for Development of Treatments

›
EurekAlert, PUBLIC RELEASE: 27-FEB-2019, Ariz. and DOWNINGTOWN, Penn., February 27, 2019 -- Critical Path Institute's (C-Path) Data Coll...
Wednesday, February 27, 2019

Minoryx recibe la aprobación de la Agencia Reguladora Española para iniciar el estudio de fase 2 en la ataxia de Friedreich

›
Mataró (Barcelona)-Charleroi (Bélgica), 27 de febrero de 2019. Minoryx Therapeutics, compañía biotecnológica especializada en el desarrollo ...

Minoryx Therapeutics lance une étude clinique de phase II dans l'ataxie de Friedreich avec l’autorisation de l'Agence Espagnole du Médicament

›
Mataró, Barcelone, Espagne et Charleroi, Belgique, le 27 février 2019 - Minoryx Therapeutics, une société spécialisée dans le développement...